CHICAGO, May 16 (Reuters) - Abbott Laboratories Inc. on Tuesday said it entered into a licensing agreement with Advanced Life Science Institute Inc. to develop a test for small-cell lung cancer, an aggressive form of the disease.
CHICAGO, May 16 (Reuters) - Abbott Laboratories Inc. on Tuesday said it entered into a licensing agreement with Advanced Life Science Institute Inc. to develop a test for small-cell lung cancer, an aggressive form of the disease.
